GL1X · GenesisL1 explorer

MolNFT v1 · #55254 · protein

Crystal structure of the first bromodomain of human BRD4 with the inhibitor GW841819X

2YEL: “Crystal structure of the first bromodomain of human BRD4 with the inhibitor GW841819X”. X-ray diffraction, 1 ligand (WSH), 1 pocket (best druggability 0.55). MolNFT v1 #55254 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
2YEL
Type
protein
Length
127 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human BRD4
UniProt
O60885
Ligands
WSH
Pockets
1 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman BRD4protein12752% helix, 0% strandO60885

Ligands and binding sites

  • WSH · Benzyl [(4R)-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]carbamate · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11190.550.8226WSH

Compared structures

  • 2YEL · Crystal Structure of the First Bromodomain of Human Brd4 with the inhibitor GW841819X · the same entry in another collection · chain A against A, TM-score 1.00
  • O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.